Enzyme Activity in Gastric Juice in Diagnosis of Gastric Carcinoma

1964 ◽  
Vol 46 (2) ◽  
pp. 239-240
Author(s):  
Leon Schif
1963 ◽  
Vol 45 (5) ◽  
pp. 614-620 ◽  
Author(s):  
D.W. Piper ◽  
Mary L. Macoun ◽  
F.L. Broderick ◽  
Barbara H. Fenton ◽  
Janet E. Builder

1984 ◽  
Vol 30 (5) ◽  
pp. 707-711 ◽  
Author(s):  
P C Will ◽  
W E Allbee ◽  
C G Witt ◽  
R J Bertko ◽  
T S Gaginella

Abstract The activity concentration of pepsin may be quantified by using azocoll as a chromogenic substrate. The measured enzyme activity is constant between pH 1.2 and 3.4 and is proportional (r = 0.61) to the activity measured with hemoglobin as substrate. The activity of purified porcine pepsin is inhibited by pepstatin A with an apparent Ki of 115 nmol/L. The azocoll method is useful for measuring changes in pepsin secretion in response to pharmacological agents. For example, pepsin activity of canine gastric juice is decreased by 80% after in vivo administration of 0.5 mg of the synthetic trimethyl prostanoid Ro 22-6923 per kilogram of body weight. The method is sufficiently sensitive to measure the pepsin activity in 0.2 microL of canine gastric juice with a CV of approximately 10%, is simpler than the hemoglobin-substrate methods, and the substrate is commercially available.


1987 ◽  
Vol 2 (2) ◽  
pp. 101-104 ◽  
Author(s):  
Dino Amador ◽  
Alberto Ravaioli ◽  
Roberta Biserni ◽  
Chiara Bonaguri ◽  
Paola Erbacci ◽  
...  

First described in 1965 as a specific antigen for cancer of the colon, CEA is now considered to be an antigen associated with many types of malignant neoplasia, although the CEA-Test's role in clinical routine has yet to be clearly defined. In the present study CEA levels in gastric juice were measured in subjects with gastric carcinoma (n = 25) and with benign gastric lesions (n = 171). CEA was significantly (p < 0.05) higher in patients with gastric carcinoma (GC) than in subjects with benign gastric lesions, other than chronic atrophic gastritis (CAG) associated with intestinal metaplasia (IM). In this latter condition CEA levels were similar to those in patients with GC. These results suggest that the assay of CEA in gastric juice could be included in the diagnostic program for gastric cancer and its precursors with the aim of assessing its utility as risk indicator in the management of precancerous conditions and lesion.


1966 ◽  
Vol 51 (2) ◽  
pp. 172-179 ◽  
Author(s):  
D.W. Piper ◽  
Eleanor M. Griffith ◽  
Louise G. Irving ◽  
Barbara H. Fenton

1970 ◽  
Vol 58 (6) ◽  
pp. 766-771 ◽  
Author(s):  
D.W. Piper ◽  
M.L. Kemp ◽  
B.H. Fenton ◽  
M.J. Croydon ◽  
A.D. Clarke

Sign in / Sign up

Export Citation Format

Share Document